0001387131-21-011775.txt : 20211203
0001387131-21-011775.hdr.sgml : 20211203
20211203170830
ACCESSION NUMBER: 0001387131-21-011775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211203
DATE AS OF CHANGE: 20211203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARLO DENNIS J PHD
CENTRAL INDEX KEY: 0001038322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36242
FILM NUMBER: 211471012
MAIL ADDRESS:
STREET 1: PO BOX 1176
CITY: RANCHO SANTA FE
STATE: CA
ZIP: 92067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp
CENTRAL INDEX KEY: 0000887247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820429727
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 997-2400
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950615
4
1
form4.xml
X0306
4
2021-12-01
0
0000887247
Adamis Pharmaceuticals Corp
ADMP
0001038322
CARLO DENNIS J PHD
C/O ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, STE 300
SAN DIEGO
CA
92130
1
1
0
0
President & CEO
Common Stock
2021-12-01
4
S
0
47870
0.785
D
296357
D
Common Stock
150709
I
By Dennis and Allison Carlo Joint Living Trust
Common Stock
5883
I
By A. Carlo as custodian for Child
The shares were sold to pay the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7784 to $0.7925, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Includes shares of common stock beneficially owned and shares of common stock issuable upon vesting of restricted stock units previously reported in Table 1 of Form 4.
/s/ David C. Benedicto, as Attorney-in-Fact
2021-12-01